Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 10/20 | 1.00 |
| ▸ | HSD11B2 | P80365 | 9/20 | 1.00 |
| ▸ | CES2 | O00748 | 5/20 | 1.00 |
| ▸ | CES1 | P23141 | 5/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PRKCH | P24723 | 1/20 | 1.00 |
| ▸ | PTPN6 | P29350 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | PTPN11 | Q06124 | 1/20 | 1.00 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 1.00 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.76 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Enoxolone SCHEMBL1878063 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL8896296 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL19248152 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL13144257 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL23016683 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL2762928 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL23252837 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL12444056 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL14071726 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 | |
| Enoxolone SCHEMBL12225660 | 1.00 | HSD11B1 (1.00) | HSD11B1HSD11B2CES2CES1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 11317 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4529452-B1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | GIULIANI SPA (IT) | 2025-12-24 | — | — | EP | claimed |
| US-20250338841-A1 | Dry Powdered Compositions and Methods and Uses Thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-11-06 | — | — | US | claimed |
| US-20250236979-A1 | COMPOSITIONS FOR ELECTROWINNING ACID MIST SUPPRESSION | W-TECH TECHNOLOGIES LTD. (CA) | 2025-07-24 | — | — | US | claimed |
| US-12356985-B2 | Dry powdered compositions and methods and uses thereof | NEOZYME INTERNATIONAL, INC. (US) | 2025-07-15 | — | — | US | claimed |
| US-20250170038-A1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | GIULIANI S.P.A. (IT) | 2025-05-29 | — | — | US | claimed |
| US-20250170082-A1 | HPDL INHIBITORS AND USES THEREOF | NEW YORK UNIVERSITY (US) | 2025-05-29 | — | — | US | claimed |
| US-20250144021-A1 | GEL FORMULATIONS FOR LOCAL DRUG RELEASE | TECHNICAL UNIVERSITY OF DENMARK (DK) | 2025-05-08 | — | — | US | claimed |
| WO-2025076059-A1 | ROCAGLATE DERIVATIVES AND USES THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| EP-4529452-A1 | DOSAGE FORMS FOR TOPICAL ADMINISTRATION OF PENTACYCLIC TRITERPENES | Giuliani S.p.A. (IT) | 2025-04-02 | — | — | EP | claimed |
| EP-3943073-B1 | BIODEGRADABLE POLYMER MICROPARTICLE CONTAINING STEROID-BASED DRUG AND PREPARATION METHOD THEREFOR | REGENBIOTECH INC (KR) | 2025-03-26 | — | — | EP | claimed |
| EP-0755675-B1 | Dermatological and/or pharmaceutical composition, process of preparation and utilization | OREAL (FR) | 1997-09-17 | — | — | EP | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| CN-1096696-A | A kind of preparation method of separating drunkenness dispelling tea | LIANG KANGRU (CN) | 1994-12-28 | — | — | CN | claimed |
| CN-1087526-A | A Gan goes anticancer preparation prescription and technology | UNIV BEIJING MEDICAL (CN) | 1994-06-08 | — | — | CN | claimed |
| EP-0496520-A1 | Novel bone acting agents | MERCK & CO. INC. (US) | 1992-07-29 | — | — | EP | claimed |
| EP-0197876-B1 | THERAPEUTICAL COMPOSITION FOR USE IN DERMATOLOGY CONTAINING IMIDAZOLIDINYL UREA AS AN ACTIVE SUBSTANCE | ANBEN (FR) | 1990-07-11 | — | — | EP | claimed |